Syntax Research’s CME Group CME Stock Holding History

Syntax Research’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,857	Closed	-$493K	–	173
2025 Q1	$493K	Sell	1,857 -147	-7%	-$36.3K	0.34%	52
2024 Q4	$465K	Sell	2,004 -9,509	-83%	-$2.19M	0.33%	47
2024 Q3	$2.54M	Buy	+11,513	New	+$2.38M	1.72%	25

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Syntax Research's CME Position: Q2 2025 in Review

Syntax Research sold out of CME Group (CME) in Q2 2025, closing a stake of 1,857 shares — an estimated $493K sold.

Syntax Research first reported a position in CME in Q3 2024 and held it in 3 quarters. The position peaked at $2.54M in Q3 2024. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

Syntax Research reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
Syntax Research sold 1,857 CME Group shares in Q2 2025, an estimated $493K.
Syntax Research first reported a position in CME Group in Q3 2024 and held it in 3 quarters.
Syntax Research's CME Group position peaked at $2.54M in Q3 2024.
1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.